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ABSTRACT 
Equine grass sickness (EGS) is a frequently fatal disease of horses, responsible for the death of 
1-2% of the UK horse population annually. The etiology of this disease is currently 
uncharacterized although there is evidence it is associated with Clostridium botulinum 
neurotoxin in the gut. Prevention is currently not possible and ileal biopsy diagnosis is invasive. 
The aim of this study was to characterize the fecal microbiota and biofluid metabolic profiles of 
EGS horses, to further understand the mechanisms underlying this disease and identify metabolic 
biomarkers to aid in diagnosis. Urine, plasma and feces were collected from horses with EGS, 
matched controls (MC), and hospital controls (HC). Sequencing the16S rRNA gene of the fecal 
bacterial population of the study horses found a severe dysbiosis in EGS horses, with an increase 
in Bacteroidetes and a decrease in Firmicutes bacteria. Metabolic profiling by 
1
H nuclear 
magnetic resonance (NMR) spectroscopy found EGS to be associated with the lower urinary 
excretion of hippurate and 4-cresyl sulfate and higher excretion of O-acetyl carnitine and 
trimethylamine-N-oxide (TMAO). The predictive ability of the complete urinary metabolic 
signature and using the four discriminatory urinary metabolites to classify horses by disease 
status was assessed using a second (test) set of horses. The urinary metabolome and a 
combination of the four candidate biomarkers showed promise in aiding the identification of 
horses with EGS. Characterization of the metabolic shifts associated with EGS offers the 
potential of a non-invasive test to aid pre-mortem diagnosis. 
 
INTRODUCTION 
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Equine grass sickness (EGS) has been recognized for over 100 years, but its etiology remains 
unknown and no experimental model for the disease exists. EGS is associated with neuronal 
damage throughout the autonomic nervous system with changes seen most consistently in the 
wall of the ileum. Clinical signs observed in horses with EGS are: loss of appetite, ileus, inability 
to pass feces, large colon impaction, tachycardia and ptosis of the eyes. The etiological 
hypothesis best supported by evidence is that of toxicoinfection by Clostridium botulinum
1,2
. 
Both the organism and associated neurotoxins have been identified in the ingesta of diseased 
horses
3
. C. botulinum neurotoxins have been demonstrated to result in neuronal pathology in 
vitro, although recent evidence suggests that this pathology is not consistent with that observed 
in clinical disease cases
4
. It is unknown whether C. botulinum and/or its associated neurotoxins 
are present in the gastrointestinal tract of diseased horses due to ingestion or due to the in situ 
production of botulinum neurotoxin by resident, commensal bacteria. The composition of gut 
microbial communities and host metabolome have not been characterized in horses affected by 
EGS. 
This study applied fecal bacterial and metabolic profiling approaches in parallel to 
determine the gut microbial and metabolic variation associated with EGS. The intestinal 
microbiota of the healthy horse and that of horses suffering from colitis has recently been defined 
using bacterial DNA sequencing 
5–7
. Metabonomic analysis of biofluids allows for the capturing 
of products arising from the horse genome and are those derived from environmental sources 
such as the gut microbiota, diet and interactions between these and the host. Combining 
sequencing approaches to bacterial community profiling and metabonomics has been widely 
used to study the effects of disease in both human and mice, however their use in equine research 
is rare
8–10
. In this study we have used an integrated metabolic and bacterial community profiling 
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approach, to assess the systemic effect of EGS on the horse. Our aim is to identity potential 
diagnostic markers for EGS and to inform hypotheses on disease aetiology. 
 
EXPERIMENTAL SECTION 
Study populations and sample collection 
Urine, plasma and feces samples were collected over a two year period (2012-2013) from a total 
of 40 horses: 19 with EGS, 15 co-grazing, matched controls (MC) and 6 hospital control (HC) 
horses. Cases of EGS were sampled at the Philip Leverhulme Equine hospital, pre-mortem, 
before laparotomy and 16 were confirmed with histological analysis of an ileal biopsy
11
 (Table 
S1). All urine was sampled free flowing, feces were collected during rectal examination during 
clinical investigation in ill horses and after defecation from healthy control horses. Selection 
criteria for matched control (MC) horses were: grazing in the same field at the same time as 
affected horses and matched on sex and age where possible. As EGS is highly seasonal in 
prevalence (most cases occur between March and June
2,12–17
) samples were acquired from MC 
horses as soon as possible after presentation of the EGS case; typically within two days. HC 
horses presented with clinical signs consistent with equine grass sickness but subsequent 
investigation, including histology of an ileal biopsy in some cases, led to an alternative diagnosis. 
This group was included to identify microbial and metabolic variation unique to EGS that was 
distinct from differences caused by gastrointestinal illness. Extra information on how all 
biofluids were handled can be found in Supplementary Methods S1.   
To validate the statistical model created with data from EGS, MC and HC samples 
(calibration set), a comparison test set of new samples was collected during 2014. This 
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comprised urine, blood and fecal samples from five histologically confirmed cases of acute grass 
sickness and ten healthy Thoroughbred racehorses (five in race training and fed on concentrates, 
five out of training and fed grass only).  All samples were stored at -80°C until defrosted for 
analysis. (Information on all horses sampled can be found in Table S1 in the supporting 
information.) 
 
Fecal bacteria DNA sequencing 
Bacterial DNA was extracted from 31 faecal samples (13 EGS, 5 HC and 13 MC from the 
calibration set) amplified using PCR of the V4 region of the 16S rRNA gene, before being 
analyzed on the MiSeq Illumina
 
platform at the Centre for Genomic Research, Liverpool. 
Detailed methodology for the preparation of feces for bacterial DNA sequencing is provided in 
supporting information (Supplementary Methods S2).  
Filtering and processing of the raw reads was performed using QIIME version 1.6.0
18
. 
Sequences were clustered into OTUs at the level of 96% similarity by reference-based picking 
with the USEARCH programme in QIIME version 1.8.0. OTUs were classified using the 
Ribosomal Database Project (RDP) classifier 2.0
19
. Sequences from each OTU were aligned 
using PyNast
18
 and a phylogenetic tree was built using ‘Fasttree’
20
. Alpha rarefaction analysis 
was performed using the script ‘multiple_rarefactions.py’ and beta diversity analysis using 
‘jackknifed_beta_diversity.py’. The difference between the alpha rarefaction values of EGS 
horses compared to control horses was assessed using a Kruskal-Wallis test. Taxa summary plots 
were generated using ‘summarize_taxa_through_plots.py’ at phyla and class levels of taxonomic 
classification. Linear discriminant analysis on effect size (LEfSe)
21
 was used to identify bacterial 
taxa that were significantly different between the faeces of the three groups of horses sampled. 
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Sequencing files were submitted the European Nucleotide Archive and can be found open access 
in study PRJEV11642. 
 
1
H NMR spectroscopic analysis of biofluids 
All urine samples were prepared for 
1
H NMR analysis by adding 200 µl phosphate buffer (pH 
7.4; 100% D2O) containing 1 mM of the internal standard 3-trimethylsilyl-1-[2,2,3,3-2H4] 
propionate (TSP) to 400 µl of each sample. All plasma samples were prepared by adding 450 µl 
saline solution (100% D2O) to 100 µl of each sample. Each fecal sample (30 mg) was combined 
with 1.2 ml phosphate buffer prior to lysis by bead beating for 10 minutes. All fecal samples 
were then centrifuged for 10 minutes at 16,000 g, the pellet discarded and the supernatant 
transferred. This was repeated on two further occasions to ensure the removal of all solid 
particles in the samples. All biofluid samples were transferred to 5 mm NMR tubes before 
1
H 
NMR analysis. Spectroscopic analysis of all samples was carried out on a 700 MHz Bruker 
NMR spectrometer equipped with a cryo-probe. Standard one-dimensional 
1
H NMR spectra 
were acquired for all urine and fecal samples with water peak suppression using a standard pulse 
sequence. Water suppressed Carr-Purcell-Meiboom-Gill (CPMG) spin echo spectra were 
acquired for plasma samples. CPMG experiment was used to measure plasma metabolic profiles 
as this attenuates broad signals arising from macromolecules found in plasma, which may mask 
peaks from lower weight molecules. For all samples, 8 dummy scans were followed by 256 scans 
and collected in 64K data points. Chemical shifts in the urine and fecal spectra were referenced 
to the TSP singlet at δ 0.0. A spectral width of 20 ppm and an acquisition time per scan of 3.12 
seconds was used. 
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1
H
 
NMR spectra were phased and baseline corrected in Topspin 3.0 before alignment and 
normalization (total intensity method) was performed in the Matlab environment (R2014a, 
Mathworks) with in-house scripts. Multivariate statistical analysis was applied to compare 
profiles of the same biofluid between study groups in the calibration set of samples. Orthogonal 
projection to latent structures-discriminant analysis (OPLS-DA) models were constructed for 
pair-wise comparisons of the study groups for each biofluid to identify metabolic variation 
between the classes. The predictive performance (Q
2
Y) of the OPLS-DA models were measured 
and only those considered significant after permutation testing (1000 permutations; p < 0.01) 
were used. Metabolites were assigned to peaks using the database of equine metabolites found in 
Escalona et al. 2015
22
 and Chenomx (NMR suite 8.2). 
 
Predictive model for potential biomarkers 
To assess the diagnostic potential of the metabolites identified from the calibration set, these 
discriminatory metabolic features were used to predict the class membership of samples from the 
test set. NMR profiles from the test set were centred to the mean of the calibration set and 
divided by the standard deviation of the calibration set to mirror the spectra processing used to 
construct the original model. Using the prediction function in the OPLS-DA model class 
membership (where 1 = disease and 0 = control) was predicted for each test set sample based 
upon both the complete urinary metabolic profile and the profile created using four candidate 
urinary metabolite biomarkers (4-cresyl sulfate, O-acetyl carnitine, hippurate and TMAO) for 
EGS. The concentration of a single urinary metabolite to predict disease state was assessed by 
building linear regression models with the concentration of the metabolite in the calibration set 
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and using these to predict disease state for the test set with the concentrations of that metabolite 
in the test set. 
 
RESULTS AND DISCUSSION 
EGS is associated with reduced diversity of fecal microbiota. 
Miseq analysis of bacterial DNA extracted from equine feces resulted in a total read count 
number across all samples of 10,085,808 (minimum of 173,469 and maximum of 595,973). The 
mean number of counts per samples run was 373,548 and the median was 386,902, with a 
standard deviation of 92,907. To explore the differences in fecal bacterial community diversity 
between groups, within-sample bacterial diversity (alpha diversity, measured as observed 
species) was compared. Figure 1 shows the range of diversity measures for each group of horses 
at a sampling depth of 200,000 sequences per sample. Fecal samples from EGS horses had the 
lowest diversity (1,695 ± 720 observed species), with MC horses being highest (3,361 ± 474) and 
HC horses having an intermediate bacterial diversity (3,148 ± 504). A Kruskal-Wallis test 
showed that the difference in the number of observed species between EGS horses and the two 
control groups was statistically significant (p < 0.01). A second measure of alpha diversity, 
Chao1, was calculated showing significantly lower diversity in EGS horses compared to the two 
control groups (Kruskall Wallis test; p < 0.01). Beta diversity analysis showed that the bacterial 
diversity within the feces of horses with grass sickness is different and has greater variation than 
the two control groups (Figure S1). As the fecal microbiota has been shown to be representative 
of the colonic microbiota
6,23
 this indicates that EGS is associated with a significant reduction in 
the diversity of colonic microbiota of the colon. Reduced bacterial diversity is generally 
Page 8 of 32
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9 
 
associated with poor health and has been observed previously with  equine colitis and recurrent 
Clostridium difficile infection in humans
5,24
. Reduced diversity can impair the competitive 
exclusion capacity of the gut microbiota and could allow potential bacterial pathogens to 
establish, such as C. botulinum. 
 
 
 
 
 
 
Figure 1. Alpha diversity levels, measured as observed number of species, for the fecal 
bacterial communities of horses with grass sickness (EGS), hospital controls (HC) and matched 
controls (MC) at 200,000 sequences per sample. 
 
EGS is associated with bacterial dysbiosis. 
To explore the differences in fecal bacterial communities the relative abundance of bacterial 
orders in each sample was visualized as percentage bars for the total reads. Figure 2A shows 
phylum level average proportion; a higher relative abundance of Bacteroidetes and 
Proteobacteria was observed in EGS horses compared to the control horses, while the relative 
abundance of Firmicutes and Verrucomicrobia was lower. A similar pattern can be seen in the 
percentage reads plots at class level; an increase in the relative abundance of Bacteroidia and 
Gammaproteobacteria and a decrease in the relative abundance of  Clostridia and Verruco-5 in 
the faeces of EGS horses compared to the two control groups (see Figure S2). Differences were 
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also observed at order-level (Figure 2B); EGS horses had a higher relative abundance of 
Bacteroidales, Fusobacteriales and Enterobacteriales compared to the fecal microbiota of MC 
and HC horses. Conversely, Clostridiales, Spirochaetales and Fibrobacterales were lower in 
relative abundance. These changes were consistent with those reported in the faecal microbiota 
of horses with colitis; where an increase in the relative abundance of Bacteroidetes and a 
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decrease in Firmicutes have previously been reported
5
. These bacterial modulations have been 
observed in humans with Parkinson’s disease, inflammatory bowel disease and irritable bowel 
syndrome
25–28
. Interestingly, biomarkers of systemic inflammation have also been seen in EGS
29
. 
A chemical trigger or genetic predisposition is hypothesized to initiate gut microbial-associated 
inflammation in humans
30
. EGS often occurs after a change in pasture/diet and only to specific 
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horses, suggesting that both genetic and environmental factors may contribute to the disease. 
Inflammation in EGS horses may be an immunological response to a compositional shift in the 
gut microbiota towards an inflammatory population. However, it is also plausible that bacterial 
alterations could result from changes in the gastrointestinal environment following the onset of 
EGS
31
. 
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Figure 2. Percentages of total identifiable reads for prominent bacterial (A) phyla and (B) orders 
identified following sequencing of fecal bacterial DNA. Each bar is an average for the three 
groups of horses sampled. The key for (A) notes the dominant bacterial phyla represented by 
each coloured bar and for (B) depicts the dominant bacterial class, preceded by this order’s class 
and phyla. MC, matched control horses; HC, hospital control horses; EGS, equine grass sickness 
horses. 
LEfSe analysis was performed to identify significant differences between bacterial taxa 
abundance in each group (Figure 3). 82 operational taxonomic units (OTUs) were identified as 
significantly different between the three groups, 20 of which were potential bacterial markers for 
EGS. These candidate markers belong to five bacterial classes: Clostridia (45% of the 
differential OTUs belong to this order), Gammaproteobacteria (15%), Fusobacteria (15%), 
Bacteroidia (15%), and Deltaproteobacteria (10%). Within these bacterial groups there were 
several that belong to the phyla Fusobacteria, the order Enterobacteriales, the family 
Enterobacteriaceae and the genus Veillonella. Fusobacteria, a phylum of Gram negative bacilli 
were increased in abundance in the feces of EGS horses. As these bacterial groups are present at 
multiple taxanomic levels; the association between these groups and EGS is more robust. These 
bacteria are present in horses with diarrhea
32
 and are higher in abundance in horses with colitis
5
 
and humans with Crohn’s disease
33
. An increase in Enterobacteriales and its bacterial family 
Enterobacteriaceae, lactate producing bacteria, may contribute to the increase in lactic acid 
which is often associated with horses suffering from intestinal disease
34
. Enterobacteriaceae 
have not been previously associated with equine disease but have been linked with Crohn’s 
disease and chronic HIV infection in humans
35,36
. 
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Figure 3. OTUs that differ between the fecal samples of equine grass sickness (EGS), 
hospital control (HC) and matched control (MC) horses from LEfSe analysis. Bars on the graph 
indicate linear discriminant analysis (LDA) scores and asterisks indicate those OTUs whose 
relative abundance is shown in Fig. 4.  
Four representative OTUs were selected from those enriched in EGS horses and four that 
were enriched in MC horses. Enterobacteriales, Megashpaera, Fusobacteriales and 
DesulfovibrioD168 were chose to represent OTUs with higher counts in EGS horses and RF4-
45B, RF3, Dehalobacterium and Sphingomonas represented OTUs with higher counts in MC 
horses. The relative abundance of these representative OTUs are presented in Figure 4. The four 
OTUs increased in relative abundance in MC horses were not seen to increase in all individuals, 
and could also be found at a high relative abundance in some EGS and HC horses (Figure 4A). 
The four OTUs identified as significantly higher in relative abundance in EGS horses were not 
ubiquitously increased in all EGS horses sampled (Figure 4B). This suggests that EGS may be 
associated with a variable bacterial signature capable of evoking a host response. Notably, OTUs 
with a higher relative abundance in EGS horses were universally absent from all MC horses. 
Figure 4. (A) The relative abundance of four representative OTUs with high LDA scores 
in the fecal microbiota of matched control horses (n = 13) and (B) the relative abundance four 
representative OTUs with high LDA scores in horses with equine grass sickness (n = 12). OTUs 
chosen from Fig. 3 to represent differences within the two groups of horses on the basis of high 
LDA scores and belonging to different taxonomic groups. Bars in each plot of (A) and (B) 
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correspond to individual horses and colours indicate the group the horses belong to. The solid 
line corresponds to the mean of each group and the dashed line is the median. 
Epidemiological data suggests an association between C. botulinum and EGS
1,2
. Our 
analysis identified a lower relative abundance of the bacterial family Clostridia, in which C. 
botulinum resides, in the fecal microbiota of EGS compared to MC. As such, this study provides 
no evidence to support the C. botulinum hypothesis but nor does it preclude its involvement. It is 
possible that an unknown environmental trigger could initiate autochthonous C. botulinum to 
produce the neurotoxin or that horizontal gene transfer could occur
37
, leading to botulinum 
neurotoxicosis. 
 
Gut microbial-mammalian co-metabolism is perturbed by EGS.  
Metabolic profiles were captured from urine, plasma and feces obtained from all horses sampled. 
An example of 
1
H NMR spectra obtain from each type of equine biofluids can be seen in Figure 
S3. A multivariate OPLS-DA model with strong discriminative ability (Q
2
Y = 0.82) was 
obtained comparing the urinary metabolic profiles of EGS and MC horses (Figure 5). From this 
analysis, EGS horses were found to excrete lower amounts hippurate and 4-cresol, both known 
gut microbial-host co-metabolites compared to MC horses. Hippurate is a carboxylic acid formed 
from the gut bacterial metabolism of benzyl alcohol to benzoate, which is absorbed from the gut 
and subsequently metabolized by the horse to form hippurate. This metabolite has previously 
been detected in horse urine
22
 and reduced excretion reflects changes in the metabolic output of 
the gut microbiota. A reduced hippurate excretion been associated with human inflammatory 
bowel diseases
38–41
 and blood hippurate has recently been associated with bacterial community 
diversity within human faeces
42
. 4-cresyl sulfate excretion was lower in EGS horses compared to 
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MC. This metabolite is formed from the bacterial metabolism of tyrosine to 4-cresol, which is 
absorbed and sulfated in the host to produce 4-cresyl sulfate. As the Clostridium genus are 
known producers of cresol
43
, the lower excretion of 4-cresyl sulfate is consistent with the lower 
abundance of bacteria from this genus in EGS horses. 
 
Figure 5. Coefficients plot for the OPLS-DA model comparing the urinary metabolic 
profiles of horses with grass sickness and their matched controls (Q
2
Y = 0.82). The model was 
constructed with one orthogonal component. 
Horses with EGS were found to excrete higher amounts of O-acetyl carnitine and 
trimethylamine-N-oxide (TMAO) in EGS urine compared with MC urine. TMAO is produced 
when choline is metabolized by bacteria to trimethylamine and subsequently oxidised in the 
host’s liver to TMAO
44
. Proteobacteria and Verrucomicrobia were more abundant in the feces 
of EGS horses compared to MC and are known to metabolize choline. O-acetyl carnitine 
excretion is synthesized from acyl-CoA and carnitine and is known to have neuroprotective 
properties in small and large animal models
45,46
. O-acetyl carnitine is previously unreported in 
the urine of horses, so the significance of its association with EGS is unknown. 
Perturbations to the plasma and fecal metabolome associated with EGS can be found in 
supporting information (Figures S4 and S5), however the predictive ability of these models was 
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lower than that of urine (Q
2
Y = 0.40 and 0.62 respectively). Glucose and glycerol were observed 
to be increased in the plasma of EGS horses and 1-methyl histidine, p-hydroxy-phenylacetate, 
valine, citrate, glutamine, acetate and β-aminoisobutyrate were decreased in the plasma of EGS 
horses when compared to MC horses. A reduction in amino acids in the plasma of horses with 
EGS has previously been reported
47
. This may be linked to a reduction in gut motility caused by 
EGS which could potentially prevent dietary amino acids from reaching the colon and being 
absorbed. Increased plasma glucose is consistent with previous reports
48
 and is a non-specific 
finding in horses with intestinal disease
49–52
. Elevations in both plasma glucose and glycerol is 
associated with an increase in the sympathetic output of horses with intestinal disease
51
, which is 
consistent with stimulation of the sympathetic nervous system seen in horses with EGS
53
. Fecal 
samples from EGS horses contained higher amounts of phenylacetylglycine (PAG) and glycerol 
than controls, whereas methanol concentration was lower. OPLS-DA pairwise comparisons 
between EGS and HC were also carried out but all models built had poor predictive ability (Q
2
Y 
< 0.1). This may be due to the wide range of other intestinal diseases included in the HC group, 
and therefore a wider range of metabonomic differences in biofluids. EGS predominately affects 
the gastrointestinal system and potentially the gastrointestinal intestinal bacterial environment; 
this may explain why the most significant changes identified in the urinary metabolic profile are 
associated with bacteria-horse co-metabolites. 
                                                                                                                                                                                                        
Biomarker signature of EGS is able to predict class membership in an independent study 
population. 
The OPLS-DA model constructed on the urinary metabolic profiles of the horses (calibration set) 
was used to predict the class membership (control vs. EGS) of urine samples collected from an 
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independent set of horses (test set; n = 15, Figure 6). The complete urinary metabolic phenotype 
was a good discriminator for horses with EGS compared to healthy horses (Figure 6A) and the 
ROC curve for this model showed good sensitivity and specificity (Figure S6A).  The predicted 
class value of all samples from test set EGS samples were greater than 0 (0.61 ± 0.39), where the 
true value was 1, and the predicted class value for all but one of the healthy horses was less than 
0 (-0.63 ± 0.46) for all but one of the healthy control horses (true value was 1). The use of single 
urinary metabolites was assessed using simple linear regression models, however there were 
large overlaps between boxplots of predicted class values, due to the inter-individual variation of 
the metabolite concentrations between horses (Figure S7). The use of single metabolite 
concentrations was deemed not to be useful. Plasma and fecal metabolic profiles did not 
correctly predict disease class of the test set horses and separation between the predicted class 
values for the two groups was not seen (Figure S8). 
 
Figure 6. Box plots showing the predicted class values for the independent test set of 
urine samples calculated by the predictive OPLS-DA model built using the calibration set of 
urine samples. These were constructed using (A) urinary metabolic profiles and (B) 
concentrations of urinary hippurate, 4-cresyl sulfate, O-acetyl carnitine and TMAO. The dashed 
lines indicate the precise class values for the two groups, where 0 represents controls and 1 
represents grass sickness. 
 The whole urinary metabolome was good at discriminating between EGS and control 
horses, but to use the complete equine metabolome diagnostically would be impractical in the 
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field. As such, the model based upon the urinary metabolic profiles was refined to utilize the four 
metabolites that were found to be significantly different between EGS and MC horses (p < 0.05, 
R
2
 = 0.164); hippurate, 4-cresyl sulfate, TMAO and O-acetyl carnitine. The predictive ability of 
this panel was weaker than that of the complete urinary metabolic profile. The boxplot in Figure 
6B shows that based on this refined model the two groups could be discriminated, with no 
overlap between the predicted values of the two groups. The predicted class values for all control 
horses were less than 0, while the predicted class values for the EGS horses fell between -0.04 
and 0.09. This model had good specificity and sensitivity (Figure S6B) which suggests that the 
refined model could distinguish between healthy and EGS horses (control < -0.1 and EGS > -
0.05). We acknowledge the small size of the test set used for the predictive model. The use of 
Thoroughbred racehorses for the control group, rather than co-grazing, matched controls may 
influence the predictive performance of the test. However, it is not possible to state whether this 
difference in control selection improved or reduced the predictive performance of the model. 
This is particularly true given that the test set control horses were fed a variety of diets compared 
to the calibration set. Such dietary variation is more reflective of “real-world” situations. 
Nonetheless, this small test set demonstrates the potential utility of urinary biomarkers in a rapid, 
point-of-care diagnostic test for use in the field. 
 
CONCLUSIONS 
EGS was found to have a profound impact on the community structure and function of the gut 
microbiota with downstream effects on the urinary metabolic signatures of horses. Our study 
demonstrates that EGS is associated with a reduction in the diversity of the fecal microbiota, 
alterations to its community structure and bacterial-host metabolic interactions. We have 
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demonstrated that collectively urinary 4-cresyl-sulfate, hippurate, TMAO and O-acetyl carnitine 
have the potential to discriminate EGS horses from others.  Given the lack of non-invasive 
diagnostic tests for EGS this work offers promising diagnostic targets for future validation. 
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